Splet01. jan. 2024 · Description. Developer of oncology medicines intended to bring accessible, affordable, and life-saving treatments for patients with pediatric cancers. The company's medicines are designed for rare forms of ovarian and pediatric cancer to address a need in the oncology space, enabling healthcare institutions to offer treatments that overcome ... SpletShorla Pharma is a pharmaceutical company. View company Pharmbio Korea HQ Employees 17↓ 6% decrease Pharmbio Korea (한국팜비오) is a pharmaceutical company committed to importing, exporting, manufacturing, and distributing drugs.
Leaders in Product Development and Oncology Pharmaceuticals
SpletShorla pharma Company details www.shorlapharma.ie About At Shorla Pharma we develop and commercialize innovative drugs in the oncology space for women’s and pediatric cancers. We focus on indications where existing treatments are limited, in shortage or inadequate for the target population. Splet17. avg. 2024 · +1 (414) 434-4691 About Shorla Pharma Ltd: Established in 2024 by Sharon Cunningham and Orlaith Ryan, Shorla Pharma is a privately held, Ireland and U.S. based specialty pharmaceutical company... thailand business registration number
US FDA approves Shorla’s oncology drug for T-cell leukaemia
Splet03. jun. 2024 · Shorla Pharma Ltd is a privately held, Irish based specialty pharmaceutical company with an advanced pipeline of innovative oncology drugs for women's and … Splet10. nov. 2024 · Shorla Pharma Ltd is a privately held, Irish based specialty pharmaceutical company with an advanced pipeline of innovative oncology drugs for women's and pediatric cancers. The company... SpletShorla Pharma Announces Partnership with EVERSANA to Support the Launch and Commercialization of T-cell Leukemia Treatment GENinCode announces major US commercialisation partnership with EVERSANA Resverlogix and EVERSANA Announce Partnership to Support the Launch of Apabetalone for COVID-19 in the United States and … thailand business tax